Brandinium

Trademark search for:

ONCOCIDIN

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2012-06-19 — Application filed
  • 2012-06-22 — Application filed
  • 2012-06-27 — Application filed
  • 2012-10-03 — Assigned to examiner
  • 2012-10-12 — Suspension letter written
  • 2012-10-12 — Notification of letter of suspension e-mailed
  • 2012-10-12 — Letter of suspension e-mailed
  • 2013-04-15 — Assigned to lie
  • 2013-04-23 — Suspension inquiry written
  • 2013-04-23 — Inquiry to suspension e-mailed
  • 2013-04-23 — Notification of inquiry as to suspension e-mailed
  • 2013-10-22 — Teas response to suspension inquiry received
  • 2013-10-29 — Attorney/dom.rep.revoked and/or appointed
  • 2013-10-29 — Applicant/correspondence changes (non-responsive) entered
  • 2013-10-29 — Teas revoke/app/change addr of atty/dom rep received
  • 2013-11-19 — Application abandoned
  • 2013-11-19 — Application abandoned
  • 2013-11-19 — Application abandoned
  • 2014-01-16 — Suspension letter written
  • 2014-01-16 — Letter of suspension e-mailed
  • 2014-01-16 — Notification of letter of suspension e-mailed
  • 2014-01-17 — Notice of reinstatement mailed
  • 2014-07-16 — Suspension inquiry written
  • 2014-07-16 — Inquiry to suspension e-mailed
  • 2014-07-16 — Notification of inquiry as to suspension e-mailed
  • 2015-01-06 — Teas response to suspension inquiry received
  • 2015-01-07 — Suspension letter written
  • 2015-01-07 — Letter of suspension e-mailed
  • 2015-01-07 — Notification of letter of suspension e-mailed
  • 2015-01-07 — Teas/email correspondence entered
  • 2015-01-07 — Correspondence received in law office
  • 2015-02-18 — Automatic update of assignment of ownership
  • 2015-07-08 — Suspension inquiry written
  • 2015-07-08 — Inquiry to suspension e-mailed
  • 2015-07-08 — Notification of inquiry as to suspension e-mailed
  • 2016-01-06 — Teas response to suspension inquiry received
  • 2016-01-11 — Suspension letter written
  • 2016-01-11 — Letter of suspension e-mailed
  • 2016-01-11 — Notification of letter of suspension e-mailed
  • 2016-01-11 — Teas/email correspondence entered
  • 2016-01-11 — Correspondence received in law office
  • 2016-07-11 — Suspension inquiry written
  • 2016-07-11 — Inquiry to suspension e-mailed
  • 2016-07-11 — Notification of inquiry as to suspension e-mailed
  • 2016-07-11 — Suspension checked - to attorney for action
  • 2017-01-05 — Teas response to suspension inquiry received
  • 2017-01-13 — Suspension letter written
  • 2017-01-13 — Letter of suspension e-mailed
  • 2017-01-13 — Notification of letter of suspension e-mailed
  • 2017-01-13 — Teas/email correspondence entered
  • 2017-01-13 — Correspondence received in law office
  • 2017-07-20 — Suspension inquiry written
  • 2017-07-20 — Inquiry to suspension e-mailed
  • 2017-07-20 — Notification of inquiry as to suspension e-mailed
  • 2017-11-21 — Teas response to suspension inquiry received
  • 2017-12-01 — Assigned to lie
  • 2017-12-05 — Teas/email correspondence entered
  • 2017-12-05 — Correspondence received in law office
  • 2017-12-30 — Suspension letter written
  • 2017-12-30 — Letter of suspension e-mailed
  • 2017-12-30 — Notification of letter of suspension e-mailed
  • 2018-07-03 — Suspension checked - to attorney for action
  • 2018-07-05 — Suspension inquiry written
  • 2018-07-05 — Inquiry to suspension e-mailed
  • 2018-07-05 — Notification of inquiry as to suspension e-mailed
  • 2018-12-20 — Attorney/dom.rep.revoked and/or appointed
  • 2018-12-20 — Teas revoke/app/change addr of atty/dom rep received
  • 2018-12-21 — Teas response to suspension inquiry received
  • 2018-12-26 — Assigned to lie
  • 2018-12-27 — Approved for pub - principal register
  • 2018-12-27 — Teas/email correspondence entered
  • 2018-12-27 — Correspondence received in law office
  • 2019-01-16 — Notification of notice of publication e-mailed
  • 2019-02-05 — Published for opposition
  • 2019-02-05 — Official gazette publication confirmation e-mailed
  • 2019-04-02 — Noa e-mailed - sou required from applicant
  • 2019-09-26 — Sou teas extension received
  • 2019-09-26 — Sou extension 1 filed
  • 2019-09-26 — Sou extension 1 granted
  • 2019-09-28 — Notice of approval of extension request e-mailed
  • 2020-03-30 — Sou teas extension received
  • 2020-03-30 — Sou extension 2 filed
  • 2020-03-30 — Sou extension 2 granted
  • 2020-04-01 — Notice of approval of extension request e-mailed
  • 2020-09-29 — Sou teas extension received
  • 2020-09-29 — Sou extension 3 filed
  • 2020-09-29 — Sou extension 3 granted
  • 2020-10-01 — Notice of approval of extension request e-mailed
  • 2021-03-08 — Sou teas extension received
  • 2021-03-08 — Sou extension 4 granted
  • 2021-03-08 — Sou extension 4 filed
  • 2021-03-10 — Notice of approval of extension request e-mailed
  • 2021-09-29 — Sou teas extension received
  • 2021-09-29 — Sou extension 5 filed
  • 2021-10-04 — Case assigned to intent to use paralegal
  • 2021-10-04 — Sou extension 5 granted
  • 2021-10-05 — Notice of approval of extension request e-mailed
  • 2022-05-09 — Application abandoned
  • 2022-05-09 — Application abandoned
  • 2022-05-09 — Final status recorded

Owner Information

NOVAVIVE INC.
BELLEVILLE, ONTARIO CA
NOVAVIVE INC.
BELLEVILLE, ONTARIO CA
Bioniche Life Sciences Inc.
Belleville, Ontario CA

Correspondent

Patrick J. Jennings Pillsbury Winthrop Shaw Pittman, LLP
1200 Seventeenth Street, NW
Washington, DC 20036
UNITED STATES

Filing Details

Filing Date:
2012-06-19
Status Date:
2022-05-09
Category:
Pharmaceuticals
Filing Year:
1997

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.